ITRM•globenewswire•
Iterum Therapeutics Provides Business Update
Summary
DUBLIN and CHICAGO, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum” or “we”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today provided a business update.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on December 5, 2025 by globenewswire